Search

In conversation with Fateh Ahmad

We spoke to Fateh Ahmad about his career in plastic & craniofacial surgery, advice to those new to the field and his new role as President of the RSM Section of Plastic Surgery Can you tell us a little bit...

In conversation with Prof Ashraf Badawi

We were delighted to speak with Professor Ashraf Badawi about his distinguished career in dermatology. You are internationally recognised in the field of dermatology – can you tell us a little bit about your background? I come from a scientific...

In conversation with Harryono Judodihardjo

We were delighted to catch up with Harryono Judodihardjo, esteemed Dermatologist and Director of Belgravia Dermatology. Can you tell us a little bit about what led you into the field of dermatology and what have been the highlights so far?...

In conversation with Cameron McIntosh

We were delighted to catch up with Cameron McIntosh, ENT and Facial Plastic Surgeon and Founding President of the Society of Rhinoplasty Surgeons of South Africa (SORSSA). Can you tell us a little bit about what led you into the...

In conversation with Wendy Lewis

We were delighted to catch up with the legendary Wendy Lewis about her career in the aesthetic world and plans for this year’s AMWC. Can you tell us a little bit about what led you into the field of aesthetic...

Melanoma skin cancer: how can we improve early detection in the UK?

With melanoma rates increasing globally, should there be screening of high-risk groups? Stephen Hayes takes a look at how Australia has reduced its melanoma mortality and asks whether a similar model should be adopted elsewhere. In Britain, some 16,000 new...

Off-label cosmetic use of botulinum toxin in the lower face

Botulinum toxin A (BoNTA) is commonly used as an off-label cosmetic modality to improve the ageing lower face and neck, and may be used as a single line treatment or in combination with other procedures, such as dermal fillers [1]....

Response to the Keogh Review

On 13 February 2014 the UK Government published its response to the Keogh Review of the regulation of cosmetic interventions (https://www.gov.uk/government/publications/regulation-of-cosmetic-interventions-government-response). This response has been much anticipated by the fields of plastic surgery and aesthetic medicine and inevitably has provoked...

MD/PhDs or MD/MBAs: which do we need more to innovate in plastic surgery?

I would like to thank Arlen Meyers and Victor Castro for submitting this article. One of the problems that I have seen in my professional lifetime is the failure of entrepreneurs to grasp that there is no infinite health care...

Melasma treatment – what have we achieved in 42 years?

Melasma is a hyperpigmentation disorder which has been the subject of intense research over the last 40 years. As yet no definitive therapeutic strategy has been demonstrated to eradicate it or to avoid relapse. The author provides an up to...